Yebin Lu

1.1k total citations
23 papers, 881 citations indexed

About

Yebin Lu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Yebin Lu has authored 23 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Yebin Lu's work include MicroRNA in disease regulation (11 papers), RNA modifications and cancer (10 papers) and Cancer-related molecular mechanisms research (10 papers). Yebin Lu is often cited by papers focused on MicroRNA in disease regulation (11 papers), RNA modifications and cancer (10 papers) and Cancer-related molecular mechanisms research (10 papers). Yebin Lu collaborates with scholars based in China and Germany. Yebin Lu's co-authors include Ling Tang, Zhenglin Ou, Bo Yang, Yu Liu, Shuai Liang, Wei Wei, Weijia Sun, Xiaohui Duan, Qi Zhang and Xuejun Gong and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and Frontiers in Immunology.

In The Last Decade

Yebin Lu

21 papers receiving 874 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yebin Lu China 15 637 619 192 162 75 23 881
Kar Lok Kong Hong Kong 7 383 0.6× 725 1.2× 122 0.6× 56 0.3× 43 0.6× 8 872
Jianfeng Sang China 12 368 0.6× 459 0.7× 130 0.7× 97 0.6× 25 0.3× 42 692
Bai‐Quan Qiu China 12 440 0.7× 589 1.0× 88 0.5× 106 0.7× 41 0.5× 20 723
Mengying Cui China 9 409 0.6× 409 0.7× 99 0.5× 55 0.3× 41 0.5× 14 585
Guixing Jiang China 14 346 0.5× 489 0.8× 139 0.7× 114 0.7× 23 0.3× 26 676
Enhao Zhao China 16 335 0.5× 412 0.7× 162 0.8× 196 1.2× 25 0.3× 25 715
Yanzi Gu China 8 486 0.8× 669 1.1× 180 0.9× 246 1.5× 36 0.5× 13 876
S Chen China 7 298 0.5× 386 0.6× 138 0.7× 86 0.5× 141 1.9× 12 582

Countries citing papers authored by Yebin Lu

Since Specialization
Citations

This map shows the geographic impact of Yebin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yebin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yebin Lu more than expected).

Fields of papers citing papers by Yebin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yebin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yebin Lu. The network helps show where Yebin Lu may publish in the future.

Co-authorship network of co-authors of Yebin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yebin Lu. A scholar is included among the top collaborators of Yebin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yebin Lu. Yebin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jinjin, Dan Wang, Shuya Wang, et al.. (2025). Dual-targeted molybdenum nanomedicine treats acute pancreatitis by blocking mitochondrial DNA-triggered cGAS-STING signaling via ROS modulation. Journal of Controlled Release. 390. 114549–114549.
2.
Gao, Yongchao, Yebin Lu, Yang Li, et al.. (2024). Antitumor potentials of onco-microbial in Chinese patients with pancreatic cancer. Heliyon. 10(24). e40890–e40890.
3.
Sun, Xiaoqing, et al.. (2023). A DenseNet‐based feature weighting convolutional network recognition model and its application in industrial part classification. IET Image Processing. 18(3). 589–601. 2 indexed citations
4.
Ou, Zhenglin, et al.. (2023). Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275/AXIN2 in natural killer cells. Frontiers in Immunology. 14. 1271603–1271603. 5 indexed citations
5.
Lu, Yebin, et al.. (2023). Hypoxia promotes immune escape of pancreatic cancer cells by lncRNA NNT-AS1/METTL3-HuR-mediated ITGB1 m6A modification. Experimental Cell Research. 432(2). 113764–113764. 10 indexed citations
6.
7.
8.
Ou, Zhenglin, et al.. (2019). Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer. World Journal of Gastroenterology. 25(46). 6728–6742. 30 indexed citations
9.
Lu, Yebin, Ling Tang, Zhipeng Zhang, et al.. (2018). Long Noncoding RNA TUG1/miR-29c Axis Affects Cell Proliferation, Invasion, and Migration in Human Pancreatic Cancer. Disease Markers. 2018. 1–10. 49 indexed citations
10.
Zhang, Zhipeng, et al.. (2018). LncRNA BC032020 suppresses the survival of human pancreatic ductal adenocarcinoma cells by targeting ZNF451. International Journal of Oncology. 52(4). 1224–1234. 7 indexed citations
11.
Lu, Yebin, et al.. (2017). MicroRNA-613 inhibits the progression of gastric cancer by targeting CDK9. Artificial Cells Nanomedicine and Biotechnology. 46(5). 980–984. 42 indexed citations
12.
Wei, Wei, Yu Liu, Yebin Lu, Bo Yang, & Ling Tang. (2017). LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR‐133a/EGFR. Journal of Cellular Biochemistry. 118(10). 3349–3358. 168 indexed citations
13.
Chen, Hongxi, Zhipeng Zhang, Yebin Lu, et al.. (2017). Downregulation of ULK1 by microRNA‐372 inhibits the survival of human pancreatic adenocarcinoma cells. Cancer Science. 108(9). 1811–1819. 38 indexed citations
14.
Liang, Shuai, et al.. (2017). The lncRNA XIST interacts with miR-140/miR-124/iASPP axis to promote pancreatic carcinoma growth. Oncotarget. 8(69). 113701–113718. 28 indexed citations
15.
Liang, Shuai, et al.. (2016). MicroRNA-140 regulates cell growth and invasion in pancreatic duct adenocarcinoma by targeting iASPP. Acta Biochimica et Biophysica Sinica. 48(2). 174–181. 20 indexed citations
16.
Lu, Yebin, Juanjuan Hu, Weijia Sun, Xiaohui Duan, & Xiong Chen. (2015). Hypoxia-mediated immune evasion of pancreatic carcinoma cells. Molecular Medicine Reports. 11(5). 3666–3672. 43 indexed citations
17.
Sun, Weijia, et al.. (2015). MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1. OncoTargets and Therapy. 9. 99–99. 43 indexed citations
18.
Lu, Yebin, et al.. (2014). Nitric oxide signaling pathway activation inhibits the immune escape of pancreatic carcinoma cells. Oncology Letters. 8(6). 2371–2378. 3 indexed citations
19.
Chen, Xiong, Jie Liao, Yebin Lu, Xiaohui Duan, & Weijia Sun. (2010). Activation of the PI3K/Akt Pathway Mediates Bone Morphogenetic Protein 2-Induced Invasion of Pancreatic Cancer Cells Panc-1. Pathology & Oncology Research. 17(2). 257–261. 41 indexed citations
20.
Duan, Xiaohui, Xiong Chen, Yebin Lu, et al.. (2010). Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer. Medical Oncology. 28(2). 466–474. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kar Lok Kong Breakdown of academic impact, for papers by Jianfeng Sang Breakdown of academic impact, for papers by Bai‐Quan Qiu Breakdown of academic impact, for papers by Mengying Cui Breakdown of academic impact, for papers by Guixing Jiang Breakdown of academic impact, for papers by Enhao Zhao Breakdown of academic impact, for papers by Yanzi Gu Breakdown of academic impact, for papers by S Chen
Rankless by CCL
2026